RGNX

REGENXBIO Inc.
$7.01 +1.74%

Recent alerts on RGNX

All signals →
News Why Is Clearside Biomedical Stock Gaining Today?
14d ago
News FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
14d ago
News Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?
14d ago
News Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
14d ago
Scanner Large down move: 37.8% (2.9x normal daily movement)
17d ago
Short volume Short volume 65% of volume (3.2σ)
17d ago
Scanner Large down move: 37.8% (3.0x normal daily movement)
18d ago
Short volume Short volume 64% of volume (3.0σ)
18d ago
News Regenxbio outlines potential accelerated approval path for RGX-202 in 2027 following pivotal Phase III primary endpoint result
18d ago
SEC filing RGNX Reports Q1 2026 Revenue $6.4M, $1.72 Loss per Share
19d ago
Insider trade Sale by Steve Pakola (Chief Medical Officer)
19d ago
News FDA head Makary defends drug application rejections amid criticism
27d ago
SEC filing RGNX Settles GSK Sublicense Dispute, Pays $10M, Mutual Release Signed March 18, 2026
73d ago
Insider trade Sale by Steve Pakola (Chief Medical Officer)
81d ago
News Biotech firm stocks rise on FDA vaccine head’s exit
85d ago
News Regenxbio outlines 2026 Duchenne, wet AMD, and diabetic retinopathy milestones while targeting pivotal data releases
88d ago
SEC filing RGNX Reports $12.3M Q4 Rev, $0.08 EPS, Advances RGX-202 Phase I/II Data, $100M AbbVie Milestone, $500M Potential Deal, 2026 Catalysts
89d ago
News REGENXBIO Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – RGNX
105d ago
News RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
105d ago
News Regenxbio stock drops on FDA setback for RGX-121 gene therapy
112d ago
News Biggest stock movers Tuesday: ON, CRDO, and more
112d ago
News FDA Denies Regenxbio Gene Therapy in Latest Rare Disease Setback
112d ago
News RGNX Investors Have Opportunity to Join REGENXBIO Inc. Fraud Investigation with the Schall Law Firm
118d ago
News Regenxbio Plummets After Brain Tumor Found in Trial Participant
125d ago
News REGENXBIO falls after FDA clinical hold on gene therapies
125d ago

Get push alerts for RGNX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS